Table 2.
Pearson’s correlation analysis between sUA levels (mg/dL) and variables of interest in merged and separated study groups. The correlation coefficient r and significance are presented. For significance: a, p < 0.05; b, p < 0.01; c, p < 0.001; d, p < 0.0001.
| Parameters | Whole Population | PWS Group | Control Group |
|---|---|---|---|
| Age (years) | −0.15 a | −0.17 | −0.17 |
| BMI (kg/m2) | 0.42 d | 0.11 | 0.57 d |
| Waist (cm) | 0.63 d | 0.18 | 0.80 d |
| WHR | 0.38 d | 0.22 a | 0.51 d |
| FM (%) | 0.16 a | −0.08 | 0.31 d |
| FFM (kg) | 0.59 d | 0.39 d | 0.65 d |
| FFMI | 0.56 d | 0.25 a | 0.65 d |
| REE (kcal/24 h) | 0.63 d | 0.37 d | 0.63 d |
| REE/pREE | 0.05 | 0.16 | −0.24 b |
| REEFFM | −0.18 b | 0.01 | −0.23 b |
| RQ (VO2/VCO2) | −0.15 a | −0.17 | −0.15 |
| Glucose (mg/dL) | 0.05 | 0.28 b | 0.01 |
| Insulin (mIU/mL) | 0.37 d | 0.27 b | 0.42 d |
| HOMA-IR | 0.33 d | 0.30 b | 0.34 d |
| CHO (mg/dL) | 0.07 | 0.08 | 0.03 |
| HDL (mg/dL) | −0.39 d | −0.29 b | −0.42 d |
| LDL (mg/dL) | 0.17 c | 0.17 | 0.14 |
| Triglycerides (mg/dL) | 0.33 d | 0.29 b | 0.33 d |
| CRP (mg/dL) | 0.18 b | 0.16 | 0.26 c |
| Fibrinogen (mg/dL) | 0.15 a | 0.07 | 0.18 a |
For abbreviations: BMI, body mass index; WHR, waist-to-hip ratio; FM, fat mass; FFM, fat-free mass; FFMI, FFM index calculated as FFM [kg]/height squared [m2]; REE, resting energy expenditure; REE/pREE, REE-to-predicted REE ratio; RQ, respiratory quotient; HOMA-IR, homeostatic model of insulin resistance; CHO, total cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; CRP, C-reactive protein.